FastForward Innovations Ltd - technology and life sciences sector focused investor - Notes investee Portage Biotech Inc has announced the divestment of three legacy businesses; Portage Pharmaceuticals Ltd, and its subsidiaries Portage Glasgow Ltd and EyGen Ltd, to Juvenescence Ltd.
FastForward has a 0.56% interest in the issued stock of Portage and a 0.6% interest in the issued stock of Juvenescence Ltd.
Current stock price: 10.55 pence
Year-to-date change: up 26%
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.